← Back
$TBPH All transactions

Theravance Biopharma, Inc.

A

$ Value

$0

Shares

10,430

Price

$0

Filed

May 21

Insider

Name

Miller Aine

Title

SVP, DEV & HEAD OF IRE OFFICE

CIK

0002012524

Roles

Officer

Transaction Details

Transaction Date

2025-05-19

Code

A

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

224,691

Footnotes

On April 2, 2024 the reporting person was granted a performance restricted stock unit award that vests based on the achievement of certain performance conditions and continued employment. On May 19, 2025, the performance conditions were deemed achieved as to 10,430 RSUs, and such RSUs are eligible to vest based on the reporting person's continued service. | Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction.

Filing Info

Accession No.

0001415889-25-014025

Form Type

4

Issuer CIK

0001583107

Miller Aine's History

Date Ticker Type Value
2025-11-20 TBPH F $125K
2025-08-20 TBPH F $94K
2025-05-20 TBPH F $92K
2025-05-19 TBPH A $0

Other Insiders at TBPH (90d)

Insider Bought Sold Last
Winningham Rick E
CHIEF EXECUTIVE OFFICER
2026-04-01
Farnum Rhonda
SVP, COMM & MEDICAL AFFAIRS
2026-04-01
Sawaf Aziz
SVP & CHIEF FINANCIAL OFFICER
2026-04-01
Grimaud Brett A.
SVP, GEN COUNSEL AND SECRETARY
2026-04-01